ARCHIVES

Scientists, Advocates Voice Objections To von Eschenbach’s Conflicts, 2015.

This article is from The Cancer Letter archive.

Vol. 32 No. 42 | November 22, 2006

Download PDF Visit The Full Archive

Related Articles

Afinitor Increases Overall Survival To 3.5 Years in Phase III Trial

September 26, 2014

DeVita: No Decision Yet On FCRF Award

July 17, 1987

HHS Agency Says It Has No Jurisdiction And No Cause to Act on I-ELCAP Allegations

March 2, 2012

PIs On Both Sides of Screening Controversy Testified in Tobacco Trials.

October 26, 2007

Peer Review Study Team Plans Hearing

December 12, 1975

Phase III Study: Lymphoseek Superior to Vital Blue Dye

June 24, 2011